Development of a novel mixed hemimicelles dispersive micro solid phase extraction using 1-hexadecyl-3-methylimidazolium bromide coated magnetic graphene for the separation and preconcentration of fluoxetine in different matrices before its determination by fiber optic linear array spectrophotometry and mode-mismatched thermal lens spectroscopy
- 1 January 2016
- journal article
- Published by Elsevier in Analytica Chimica Acta
- Vol. 905, 85-92
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Trace analysis of fluoxetine and its metabolite norfluoxetine. Part II: Enantioselective quantification and studies of matrix effects in raw and treated wastewater by solid phase extraction and liquid chromatography–tandem mass spectrometryJournal of Chromatography A, 2012
- Extraction of fluoxetine from aquatic and urine samples using sodium dodecyl sulfate-coated iron oxide magnetic nanoparticles followed by spectrofluorimetric determinationAnalytica Chimica Acta, 2011
- Trace analysis of antidepressants in environmental waters by molecularly imprinted polymer-based solid-phase extraction followed by ultra-performance liquid chromatography coupled to triple quadrupole mass spectrometryAnalytical and Bioanalytical Chemistry, 2009
- On-line solid phase extraction coupled to capillary LC-ESI-MS for determination of fluoxetine in human blood plasmaTalanta, 2009
- Simultaneous determination of citalopram, fluoxetine and their main metabolites in human urine samples by solid-phase microextraction coupled with high-performance liquid chromatographyJournal of Pharmaceutical and Biomedical Analysis, 2008
- Chiral selectors for enantioresolution and quantitation of the antidepressant drug fluoxetine in pharmaceutical formulations by 19F NMR spectroscopic methodAnalytica Chimica Acta, 2007
- Stir Bar Sorptive Extraction-LC-MS for the Analysis of Fluoxetine in PlasmaChromatographia, 2006
- Fluoxetine: a review on evidence based medicineAnnals of General Hospital Psychiatry, 2004
- Risks and benefits of selective serotonin reuptake inhibitors in the treatment of depression.Drug Safety, 1998
- FluoxetineDrugs, 1986